During the past decade, International Pharmaceutical Research Center conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "International Pharmaceutical Research Center" #1 sponsor was "Darnitsa Pharmaceutical Company" with 2 trials, followed by "Disphar International B.V." with 2 trials sponsored, "Midas Pharma GmbH" with 2 trials sponsored, "Mitovie Pharma Ltd" with 1 trials sponsored and "Verisfield UK Ltd. Greek Branch" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "International Pharmaceutical Research Center" #1 collaborator was "International Pharmaceutical Research Center" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "International Pharmaceutical Research Center" are "Bioequivalence" (2 trials), "Comparative Bioavailability" (2 trials), "Healthy Subjects" (2 trials), "Healthy Volunteers" (2 trials) and "Bacterial Infections" (1 trials). Many other conditions were trialed in "International Pharmaceutical Research Center" in a lesser frequency.

Most popular intervention types in "International Pharmaceutical Research Center" are "Drug" (8 trials). Other intervention types were less common.

The name of intervention was led by "Candesartan, Amlodipine, Atorvastatin" (1 trials), "Flagyl 125 mg/5 ml oral suspension" (1 trials), "Flagyl 400 mg Tablets" (1 trials), "Gliclazide 120 mg MR Tablets" (1 trials) and "Gliclazide 120 mg MR Tablets Formula A" (1 trials). Other intervention names were less common.

The vast majority of trials in "International Pharmaceutical Research Center" are 6 trials for "All" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "International Pharmaceutical Research Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in International Pharmaceutical Research Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in International Pharmaceutical Research Center, 8 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".